Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sumithira Vasu

Showing results (11-20 of 102) with videos related to

Pageof 11
Sort By:
Familial Cancer|May 8, 2026
Biallelic germline MBD4 mutations predispose to colorectal polyposis, hypermutated AML, and schwannomasJulia Cooper, Brittany L Stewart, Lauren Bokovitz, et al.
Blood|April 29, 2025
High Incidence of Severe TA-TMA Increases Mortality in adult Allogeneic Transplant recipients: A prospective MIDAS Consortium studySumithira Vasu, Qiuhong Zhao, Elizabeth Greer Miller, et al.
Leukemia & Lymphoma|October 12, 2024
Combination ruxolitinib and belumosudil is tolerable and induces responses despite treatment failure as monotherapiesJean Caputo, Ayush Peddireddi, Subodh Bhatta, et al.
Cytotherapy|April 19, 2020
Fc-engineered anti-CD33 monoclonal antibody potentiates cytotoxicity of membrane-bound interleukin-21 expanded natural killer cells in acute myeloid leukemiaRajeswaran Mani, Girish Rajgolikar, Jessica Nunes, et al.
Cardio-Oncology (London, England)|October 23, 2021
Acute cardiotoxicity after initiation of the novel tyrosine kinase inhibitor gilteritinib for acute myeloid leukemiaLisa Kim, Brian Fowler, Courtney M Campbell, et al.
Cancer|January 5, 2026
Hematopoietic effects of tagraxofusp in treatment-naive patients with blastic plasmacytoid dendritic cell neoplasmMarina Konopleva, Naveen Pemmaraju, Kendra L Sweet, et al.
Transplantation and Cellular Therapy|October 25, 2022
Bringing Patient and Caregivers Voices to the Clinical Trial Chorus: A Report From the BMT CTN Patient and Caregiver Advocacy Task ForceSumithira Vasu, Shernan G Holtan, Akiko Shimamura, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 25, 2013
FLT3L and plerixafor combination increases hematopoietic stem cell mobilization and leads to improved transplantation outcomeShun He, Jianhong Chu, Sumithira Vasu, et al.
Cancers|January 10, 2026
Pharmacologic Targeting of miR29b with Bortezomib and Sorafenib to Improve Decitabine Sensitivity in Patients with Acute Myeloid Leukemia: Results from a Phase 1 Dose-Escalation TrialShivani Handa, Kristin Koenig, Qiuhong Zhao, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 24, 2019
Comparison of Two Doses of Antithymocyte Globulin in Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell TransplantationHassan Issa, Nidhi Sharma, Qiuhong Zhao, et al.
Pageof 11

Showing results (11-20 of 102) with videos related to

Sort By:
Pageof 11
Familial Cancer|May 8, 2026
Biallelic germline MBD4 mutations predispose to colorectal polyposis, hypermutated AML, and schwannomasJulia Cooper, Brittany L Stewart, Lauren Bokovitz, et al.
Blood|April 29, 2025
High Incidence of Severe TA-TMA Increases Mortality in adult Allogeneic Transplant recipients: A prospective MIDAS Consortium studySumithira Vasu, Qiuhong Zhao, Elizabeth Greer Miller, et al.
Leukemia & Lymphoma|October 12, 2024
Combination ruxolitinib and belumosudil is tolerable and induces responses despite treatment failure as monotherapiesJean Caputo, Ayush Peddireddi, Subodh Bhatta, et al.
Cytotherapy|April 19, 2020
Fc-engineered anti-CD33 monoclonal antibody potentiates cytotoxicity of membrane-bound interleukin-21 expanded natural killer cells in acute myeloid leukemiaRajeswaran Mani, Girish Rajgolikar, Jessica Nunes, et al.
Cardio-Oncology (London, England)|October 23, 2021
Acute cardiotoxicity after initiation of the novel tyrosine kinase inhibitor gilteritinib for acute myeloid leukemiaLisa Kim, Brian Fowler, Courtney M Campbell, et al.
Cancer|January 5, 2026
Hematopoietic effects of tagraxofusp in treatment-naive patients with blastic plasmacytoid dendritic cell neoplasmMarina Konopleva, Naveen Pemmaraju, Kendra L Sweet, et al.
Transplantation and Cellular Therapy|October 25, 2022
Bringing Patient and Caregivers Voices to the Clinical Trial Chorus: A Report From the BMT CTN Patient and Caregiver Advocacy Task ForceSumithira Vasu, Shernan G Holtan, Akiko Shimamura, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 25, 2013
FLT3L and plerixafor combination increases hematopoietic stem cell mobilization and leads to improved transplantation outcomeShun He, Jianhong Chu, Sumithira Vasu, et al.
Cancers|January 10, 2026
Pharmacologic Targeting of miR29b with Bortezomib and Sorafenib to Improve Decitabine Sensitivity in Patients with Acute Myeloid Leukemia: Results from a Phase 1 Dose-Escalation TrialShivani Handa, Kristin Koenig, Qiuhong Zhao, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 24, 2019
Comparison of Two Doses of Antithymocyte Globulin in Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell TransplantationHassan Issa, Nidhi Sharma, Qiuhong Zhao, et al.
Pageof 11